QUANTUM X LABS INC. (QXL)
As-reported financials and SEC filings for QUANTUM X LABS INC. The latest annual period is FY2025. The latest reported quarter is Q2 FY2026. Financial statements come straight from the company’s EDGAR filings; valuation figures such as P/E and market cap use market data.
Snapshot
Fundamentals are from SEC filings for FY2025, the latest annual period (ended December 31, 2025). P/E and market cap are derived from stored market prices, last retrieved on a rolling basis and typically within the past week.
What changed at Quantum X Labs
- Most recent quarter Q2 FY2026: revenue $293000, down 87.2% from Q2 FY2025.
- Net loss widened to $19M in FY2025, from $12M in FY2024.
Computed from the as-reported figures in the statements below. A change we cannot state from filed figures is left out rather than estimated.
Peer comparison
Where Quantum X Labs’s fundamentals sit among the 332 software companies. Each figure is ranked only against peers that report it, from lowest (left) to highest (right).
Quantum X Labs’s return on equity of -386.6% ranks in the 1st percentile of the 285 software companies reporting it.
1 reported insider purchase (code P) totaling $21,465 in the last 90 days. For context, about 15% of companies in the universe saw any reported insider purchase (code P) in the same window. Browse insider activity →
Percentiles describe where a figure sits among industry peers reporting it (100th = highest). They are position within a peer group, not a rating, and not investment advice. Short interest ranking uses days to cover from FINRA Consolidated Short Interest data; FINRA is the owner and source of that data, included at no additional charge.
Recent insider activity
Non-derivative buys and sells (codes P/S) reported by officers, directors and 10% owners on SEC Form 4.
| Trade date | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|
2026-08-21 filed 2026-08-24 | Yoresh EliyahuDirector | Buy | 4.5K | $4.77 | $21K |
Reported non-derivative purchases and sales (codes P/S) — which may be open-market or private; excludes option exercises, grants, and shares withheld for taxes. Dates shown are the trade date; a Form 4 can be filed days to years later. A sale can be routine (e.g. a pre-set 10b5-1 plan), so read individual transactions in context. From SEC Form 4. Not investment advice.
Short interest
Total shares sold short as of each twice-monthly FINRA settlement. Rising short interest means more investors are positioned against the stock; days to cover estimates how many trading days of average volume that position represents.
| Settlement | Shares short | Change | Days to cover |
|---|---|---|---|
| 2026-08-14 | 86.5K | -17.8% | 1.92 |
| 2026-07-31 | 105.2K | -41.2% | 1.07 |
| 2026-07-15 | 178.8K | -9.2% | 2.69 |
| 2026-06-30 | 196.9K | +410.0% | 1.00 |
| 2026-06-15 | 38.6K | +3.3% | 1.00 |
| 2026-05-29 | 37.4K | +400.1% | 1.00 |
| 2026-05-15 | 7.5K | -48.2% | 1.00 |
| 2026-04-30 | 14.4K | -60.0% | 1.00 |
Source: FINRA Consolidated Short Interest. FINRA is the owner and source of the FINRA-supplied data, which is included at no additional charge for your own personal or professional use; republishing or redistributing it is not permitted. Settlement dates are shown; FINRA publishes each settlement about nine business days later, so the latest figure can be two to four weeks old. Not presented as a percentage of float. No FINRA endorsement of this product is implied. Not investment advice.
Income statement (as reported)
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Revenue | — | $26.9M | $79.6M | $96.6M | $45.2M |
| Gross profit | — | — | — | — | — |
| Operating income | $-2.2M | $-837,000 | $-7.5M | $2.7M | $541,000 |
| Net income | $-19.3M | $-12.1M | $-7.3M | $28,000 | $300,000 |
| Diluted EPS | $2.28 | $2.69 | $1.97 | $0.00 | $0.08 |
Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full details: where the numbers come from.
Balance sheet (as reported)
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Cash and equivalents | $1.0M | $24,000 | $1.8M | $4.2M | $5.2M |
| Current assets | $1.7M | $7.8M | $17.8M | $29.8M | $29.2M |
| Total assets | $10.8M | $22.0M | $43.3M | $63.7M | $51.3M |
| Current liabilities | $4.1M | $12.9M | $19.8M | $28.5M | $26.8M |
| Long-term debt | $586,000 | $496,000 | $3.1M | $2.9M | $4.3M |
| Total liabilities | $5.8M | $14.5M | $24.7M | $33.8M | $32.7M |
| Total equity | $5.0M | $7.5M | $18.6M | $29.9M | $18.5M |
Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full details: where the numbers come from.
Cash flow (as reported)
| FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|
| Operating cash flow | $-2.8M | $1.4M | $934,000 | $3.2M | $4.4M |
| Capital expenditure | — | $1,000 | $16,000 | $58,000 | $311,000 |
| Free cash flow | — | $1.4M | $918,000 | $3.2M | $4.1M |
Figures as reported to the SEC. Underlined values link to the filing they came from; dotted values are calculated by us from reported figures; “adj” means restated for a stock split (hover to see the figure as filed). Full details: where the numbers come from.
Quarterly trend (as reported)
| Quarter | Revenue | Revenue YoY | Net income | Diluted EPS |
|---|---|---|---|---|
| Q2 FY2026 | $293,000 | -87.2% | $2.5M | — |
| Q1 FY2026 | — | — | $-605,000 | — |
| Q4 FY2025 | — | — | $-566,000 | $-0.05 |
| Q3 FY2025 | $2.7M | -56.7% | $-3.4M | — |
| Q2 FY2025 | $2.3M | -68.9% | $-11.7M | $-1.61 |
| Q1 FY2025 | $2.7M | -72.7% | $-3.7M | — |
| Q4 FY2024 | $3.3M | -79.1% | $-3.3M | — |
| Q3 FY2024 | $6.3M | -60.0% | $-590,000 | — |
Latest 8 reported quarters, from company XBRL filings on SEC EDGAR.
Company facts
Selected SEC filings
Largest software peers
Monitor QXL
Get an alert when Quantum X Labs files something material, see which superinvestors own it, and ask its filings a question with cited answers.
Monitor QXL freeIncludes one free filing-grounded research answer. Or check your whole portfolio, no account needed.
Data sourced from SEC EDGAR. Figures are as-reported and may be unaudited or restated; verify against the source filing before relying on them. Informational only. Not investment advice.